153 related articles for article (PubMed ID: 21044988)
1. G2 checkpoint control and G2 chromosomal radiosensitivity in cancer survivors and their families.
Cadwell KK; Curwen GB; Tawn EJ; Winther JF; Boice JD
Mutagenesis; 2011 Mar; 26(2):291-4. PubMed ID: 21044988
[TBL] [Abstract][Full Text] [Related]
2. G(2) chromosomal radiosensitivity in Danish survivors of childhood and adolescent cancer and their offspring.
Curwen GB; Winther JF; Tawn EJ; Smart V; Whitehouse CA; Rees GS; Olsen JH; Guldberg P; Rechnitzer C; Schrøder H; Bryant PE; Sheng X; Lee HS; Chakraborty R; Boice JD
Br J Cancer; 2005 Oct; 93(9):1038-45. PubMed ID: 16234827
[TBL] [Abstract][Full Text] [Related]
3. The heritability of G2 chromosomal radiosensitivity and its association with cancer in Danish cancer survivors and their offspring.
Curwen GB; Cadwell KK; Winther JF; Tawn EJ; Rees GS; Olsen JH; Rechnitzer C; Schroeder H; Guldberg P; Cordell HJ; Boice JD
Int J Radiat Biol; 2010 Nov; 86(11):986-95. PubMed ID: 20807177
[TBL] [Abstract][Full Text] [Related]
4. G2-checkpoint abrogation in irradiated lymphocytes: A new cytogenetic approach to assess individual radiosensitivity and predisposition to cancer.
Terzoudi GI; Hatzi VI; Barszczewska K; Manola KN; Stavropoulou C; Angelakis P; Pantelias GE
Int J Oncol; 2009 Nov; 35(5):1223-30. PubMed ID: 19787278
[TBL] [Abstract][Full Text] [Related]
5. Increased G2 chromosomal radiosensitivity in cancer patients: the role of cdk1/cyclin-B activity level in the mechanisms involved.
Terzoudi GI; Jung T; Hain J; Vrouvas J; Margaritis K; Donta-Bakoyianni C; Makropoulos V; Angelakis P; Pantelias GE
Int J Radiat Biol; 2000 May; 76(5):607-15. PubMed ID: 10866282
[TBL] [Abstract][Full Text] [Related]
6. The benzene metabolite hydroquinone enhances G2-chromosomal radiosensitivity by inducing a less-efficient G2-M-checkpoint in irradiated lymphocytes.
Hatzi VI; Terzoudi GI; Pantelias GE; Spiliopoulou C; Makropoulos V
Int J Oncol; 2007 Jul; 31(1):145-52. PubMed ID: 17549415
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.
Dunst J; Neubauer S; Becker A; Gebhart E
Strahlenther Onkol; 1998 Oct; 174(10):510-6. PubMed ID: 9810318
[TBL] [Abstract][Full Text] [Related]
8. Intra-individual variation in G2 chromosomal radiosensitivity.
Curwen GB; Cadwell KK; Tawn EJ; Winther JF; Boice JD
Mutagenesis; 2012 Jul; 27(4):471-5. PubMed ID: 22422822
[TBL] [Abstract][Full Text] [Related]
9. A standardized G2-assay for the prediction of individual radiosensitivity.
Pantelias GE; Terzoudi GI
Radiother Oncol; 2011 Oct; 101(1):28-34. PubMed ID: 22014898
[TBL] [Abstract][Full Text] [Related]
10. Cell death mechanisms associated with G2 radiosensitivity in patients with prostate cancer and benign prostatic hyperplasia.
Howe O; O'Malley K; Lavin M; Gardner RA; Seymour C; Lyng F; Mulvin D; Quinlan DM; Mothersill C
Radiat Res; 2005 Nov; 164(5):627-34. PubMed ID: 16238439
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal radiosensitivity in young cancer patients: possible evidence of genetic predisposition.
Baria K; Warren C; Eden OB; Roberts SA; West CM; Scott D
Int J Radiat Biol; 2002 May; 78(5):341-6. PubMed ID: 12020425
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal radiosensitivity in Ukrainian breast cancer patients and healthy individuals.
Ryabchenko NM; Glavin OA; Shtefura VV; Anikushko MF
Exp Oncol; 2012 Jul; 34(2):121-4. PubMed ID: 23013765
[TBL] [Abstract][Full Text] [Related]
13. Genetic determination of chromosomal radiosensitivities in G0- and G2-phase human lymphocytes.
Borgmann K; Haeberle D; Doerk T; Busjahn A; Stephan G; Dikomey E
Radiother Oncol; 2007 May; 83(2):196-202. PubMed ID: 17499867
[TBL] [Abstract][Full Text] [Related]
14. G2 Chromosomal Radiosensitivity Assay for Testing Individual Radiation Sensitivity.
Haskins JS; Kato TA
Methods Mol Biol; 2019; 1984():39-45. PubMed ID: 31267418
[TBL] [Abstract][Full Text] [Related]
15. Variability of G(2) checkpoint sensitivity to low doses of X-rays (2 cGy): correlation with G(2) chromatid aberrations but not with an adaptive response.
Pretazzoli V; Salone B; Bosi A; Olivieri G
Mutagenesis; 2000 Nov; 15(6):531-5. PubMed ID: 11077006
[TBL] [Abstract][Full Text] [Related]
16. Increased individual chromosomal radiosensitivity of human lymphocytes as a parameter of cancer risk.
Dyomina EA; Ryabchenko NM
Exp Oncol; 2007 Sep; 29(3):217-20. PubMed ID: 18004249
[TBL] [Abstract][Full Text] [Related]
17. The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity.
Krueger SA; Wilson GD; Piasentin E; Joiner MC; Marples B
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1509-17. PubMed ID: 20637979
[TBL] [Abstract][Full Text] [Related]
18. Less G(2) arrest in irradiated cells of breast cancer patients than in female controls: a contribution to their enhanced chromosomal radiosensitivity?
Scott D; Spreadborough AR; Roberts SA
Int J Radiat Biol; 2003 Jun; 79(6):405-11. PubMed ID: 12963542
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition.
Baeyens A; Thierens H; Claes K; Poppe B; Messiaen L; De Ridder L; Vral A
Br J Cancer; 2002 Dec; 87(12):1379-85. PubMed ID: 12454765
[TBL] [Abstract][Full Text] [Related]
20. Checkpoint abrogation in G2 compromises repair of chromosomal breaks in ataxia telangiectasia cells.
Terzoudi GI; Manola KN; Pantelias GE; Iliakis G
Cancer Res; 2005 Dec; 65(24):11292-6. PubMed ID: 16357135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]